Conseil Stratégique MedTech: Structure your scale-up before raising capital
International MedTech consultancy
specializing in post-emergence scale-ups
We convert complexity (MDR, IA Act, multi-country deployment) into an actionable roadmap for securing your Series A/B growth.
- EU Sovereignty
- Impact & Result
- Ethics & Diversity

Why MedTech scale-ups choose us
You've raised your Seed or Series A. You're targeting Europe. You're preparing your Series B.
But coordinating technology, compliance (MDR/IA Act), multi-country deployment and lifting all at the same time will explode your timescales and your budget.
Traditional consulting firms audit and deliver reports. We orchestrate in real time: an operational PMO that coordinates your internal and external expertise to keep to your roadmap.
Our difference: international strategic PMO.
We structure your European compliance, manage your multi-country projects, coordinate your European consortia, and secure your BPI France / Horizon Europe funding.
- JuliaShift 4D Derisking Diagnostics: 360° Due Diligence
- Scale Execution: on-board COO and deployment acceleration
- Board Advisor: Vision and growth levers for Série B+
Ecosystem & Partners











Structuring your MedTech BEFORE raising capital
Free report : Due diligence BPI France 2030
Benefits:
✓ 47-point checklist validated by BPI
✓ Critical timeline 0-6 months pre-emergence
✓ 3 anonymized cases (seed → series A)
Download Blueprint (PDF)
Our services
MedTech Strategic Advisory
JuliaShift supports you from ideation to field implementation, with a structured offering to accelerate your digital health projects, strengthen your compliance, and maximize your impact on the healthcare system.
JuliaShift 4D diagnostics
Secure your valuation before due diligence
- 360° Audit Derisking
- 90-day roadmap
- Financial report
- Bpifrance expertise
Scale Execution
Fractional COO & Operational Management
- Operational Immersion
- JuliaShift protocol
- Derisking execution
- Risk co-ownership
Strategic Advisory
Board Member & Accompaniment Series B+
- Strategic guidance
- Investor Relations Support
- Network activation
- Exit optimization
Testimonials
The impact of our approach, as seen by our customers





Céline Jardy-Triola - COO Urgences Chrono
Nous avions besoin de KPIs tangibles pour nos prospects CHU et nos investisseurs. JuliaShift a structuré une méthodologie d'audit reproductible qui devient un actif commercial réutilisable sur chaque nouveau déploiement.
Université de Picardie Jules Verne
Co-enseignant Master IA Santé 2026
Modules basés sur cas d'usage industriels réels : déploiement SaMD, gestion risque production, PMO multi-acteurs. Comble le gap entre data science théorique et réalité terrain MedTech.
Latest publications
Perspectives on digital health and innovation
Explore JuliaShift’s analysis, feedback and insights into the key digital issues facing the healthcare and defense sector.
Financing innovation in healthcare: alternative MedTech models
Patient data governance in France: who controls access?
E-health Europe: Estonia values 99%, France 12%.
Ready to accelerate your digital health project?
Let’s discuss your challenges and identify together the levers to make your transformation a reality.